• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes

Introduction to 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde (CAS No. 340216-56-0)

2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde, identified by the CAS number 340216-56-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of aromatic aldehydes, characterized by its complex substitution pattern, which includes bromine, methoxy, and dichlorophenyl groups. The unique structural features of this molecule make it a valuable intermediate in the synthesis of various bioactive molecules, particularly in the development of novel therapeutic agents.

The significance of 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde lies in its potential applications as a building block for more complex pharmacophores. Aldehydes are well-known for their reactivity in forming Schiff bases, heterocycles, and other functionalized compounds. The presence of multiple substituents on the aromatic ring enhances its versatility, allowing for diverse chemical modifications that can fine-tune its biological activity. In recent years, there has been a growing interest in exploring such compounds for their potential in treating various diseases, including cancer, inflammation, and infectious disorders.

Recent advancements in computational chemistry and molecular modeling have further highlighted the importance of 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde. These techniques enable researchers to predict the binding affinity and interaction patterns of this compound with biological targets such as enzymes and receptors. For instance, studies have demonstrated that the bromine and methoxy groups can enhance binding interactions with certain protein kinases, making this compound a promising candidate for kinase inhibitors. Such inhibitors are critical in the treatment of cancers and inflammatory diseases where abnormal kinase activity plays a key role.

The synthesis of 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde involves multi-step organic reactions that require precise control over reaction conditions. The introduction of bromine at the 2-position and dichloro substituents at the 2,4-positions of the phenyl ring necessitates careful selection of reagents and catalysts to achieve high yields and purity. Additionally, the methoxy groups at the 5-position contribute to the overall stability and reactivity of the molecule. Researchers have reported efficient synthetic routes that utilize palladium-catalyzed cross-coupling reactions and nucleophilic aromatic substitutions to construct the desired framework.

In terms of biological activity, preliminary studies on 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde have shown promising results in vitro. The compound has been tested for its ability to inhibit several enzymes implicated in disease pathways. For example, its interaction with tyrosine kinases has been investigated due to their role in cell proliferation and survival. The structural motif shared by this compound with known kinase inhibitors suggests that it may exhibit similar pharmacological effects. Further research is needed to validate these findings and explore potential therapeutic applications.

The role of 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde as a scaffold for drug discovery is further underscored by its ability to undergo further functionalization. Researchers can modify the aldehyde group or introduce additional substituents to create derivatives with enhanced potency or selectivity. This flexibility makes it an attractive candidate for structure-based drug design approaches. High-throughput screening (HTS) techniques combined with virtual screening have been employed to identify lead compounds derived from 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde that show promising biological activity.

The impact of 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde extends beyond academic research into industrial applications. Pharmaceutical companies are increasingly leveraging such intermediates to develop novel drugs that meet unmet medical needs. The compound’s unique structural features offer a starting point for creating molecules with improved pharmacokinetic properties, such as better solubility or reduced toxicity. As computational methods continue to advance, the design and optimization of such compounds are becoming more efficient and cost-effective.

Future directions in the study of 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde include exploring its role in drug development through interdisciplinary approaches. Combining organic synthesis with bioinformatics and medicinal chemistry can accelerate the discovery process by identifying promising candidates more rapidly. Additionally, green chemistry principles are being integrated into synthetic methodologies to make processes more sustainable and environmentally friendly. This aligns with broader industry efforts to reduce waste and energy consumption while maintaining high standards of quality.

In conclusion, 2-bromo-4-(2,4-dichlorophenyl)methoxy-5-methoxybenzaldehyde (CAS No. 340216-56-0) represents a significant advancement in pharmaceutical chemistry due to its versatile structure and potential applications as a drug intermediate. Its unique substitution pattern allows for diverse chemical modifications that can lead to novel therapeutic agents targeting various diseases. As research continues to uncover new biological activities and synthetic strategies, this compound is poised to play a crucial role in future drug development efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)